Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 7Terminated 3Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pancreatic Neoplasms 9Carcinoma, Non-Small-Cell Lung 8Neoplasms 4Breast Neoplasms 4Lung Neoplasms 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Sarcoma 2Prostatic Neoplasms 2Platinum-Refractory Fallopian Tube Carcinoma 2Inflammatory Breast Neoplasms 2Fallopian Tube Neoplasms 2Esophageal Neoplasms 2Carcinoma, Ovarian Epithelial 2Urinary Bladder Neoplasms 1Testicular Neoplasms 1Teratoma, Testicular 1Teratoma, Ovarian 1Teratoma 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Recurrent Bladder Urothelial Carcinoma 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms, Unknown Primary 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Laryngeal Neoplasms 1

Interventions

Paclitaxel 6Radiotherapy 5Carboplatin 5capmatinib 2Radiosurgery 2Gemcitabine 2tetrathiomolybdate 1spartalizumab 1pembrolizumab 1palbociclib 1onartuzumab 1nintedanib 1fludarabine phosphate 1fludarabine 1efaproxiral 1durvalumab 1binimetinib 1aldesleukin 1Vinorelbine 1Technetium Tc 99m Sestamibi 1Taxes 1Sorafenib 1Platinum 1Nivolumab 1Neoadjuvant Therapy 1Magnetic Resonance Spectroscopy 1Interleukin-2 1Immunotherapy 1Immunoenzyme Techniques 1Gefitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Adenocarcinoma of Lung × Taxes × Clear all
NCT02059967 2015-03-19

Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC

Virginia Commonwealth University

Phase 1 Withdrawn
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡